Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe polymyositis with simvastatin use].

G Riesco-Eizaguirre1, F J Arpa-Gutiérrez, M Gutiérrez

  • 1Hospital Universitario La Paz, Madrid, España. garcilasoriesco@hotmail.com

Revista De Neurologia
|November 25, 2003
PubMed
Summary

This case study highlights a rare instance of severe polymyositis induced by simvastatin, a common cholesterol-lowering drug. Prompt corticosteroid treatment led to remission, suggesting an immune-mediated mechanism in statin-induced myotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiological-pathological correlation in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): imaging and histopathology.

Clinical radiology·2023
Same author

[Translated article] Implementation of the standardized process of drug therapy evaluation in inpatients and outpatients.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2023
Same author

Arsenic and fluorine in groundwater in northern Mexico: spatial distribution and enrichment factors.

Environmental monitoring and assessment·2022
Same author

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Computing within bacteria: Programming of bacterial behavior by means of a plasmid encoding a perceptron neural network.

Bio Systems·2022

Area of Science:

  • Pharmacology
  • Immunology
  • Neurology

Background:

  • Statin-induced myotoxicity is a known adverse effect, typically mild and reversible.
  • Polymyositis, an inflammatory muscle disease, is an uncommon presentation of statin-induced myopathy.

Observation:

  • A 75-year-old male developed proximal limb weakness, dysphagia, and myalgias while on simvastatin.
  • Elevated creatine kinase, aldolase, and LDH levels were noted.
  • Muscle biopsy revealed inflammatory cell infiltration, muscle fiber necrosis, and variation in fiber size.

Findings:

  • The patient's symptoms persisted after simvastatin withdrawal.
  • Treatment with corticosteroids resulted in clinical remission and normalization of creatine kinase levels.
  • Histopathological findings suggested an immune-mediated inflammatory myopathy rather than a non-inflammatory myopathy.

Related Experiment Videos

Implications:

  • This case suggests that immune system involvement may play a role in certain severe statin-induced myopathies.
  • Further research into the immunological mechanisms of statin-induced myotoxicity is warranted.
  • Understanding these mechanisms could lead to improved diagnosis and management of statin-related muscle damage.